Live Breaking News & Updates on ஐ மருந்துகள் ஜமைக்கா

Stay updated with breaking news from ஐ மருந்துகள் ஜமைக்கா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill Prostate Cancer Cells


 
Apollon Formularies Plc (AQSE: APOL) ( Apollon  
or the  Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange.  ....

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,

Aion Therapeutic's Dr. De La Haye to Speak at the CanEx Psychedelics Summit


Aion Therapeutic Inc.   announced today that Dr. Winston De La Haye Medical Director of the Aion International Center for Psychedelic Psychiatry in Jamaica will be speaking at the international CanEx Psychedelics Summit in Montego Bay, Jamaica taking place July 15 – 16, 2021 . Dr. De La Haye will be speaking on, ” Psychedelics, the New Frontier in Psychiatry ,” revealing for the first time Aion Therapeutic’s …
Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) announced today that Dr. Winston De La Haye Medical Director of the Aion International Center for Psychedelic Psychiatry in Jamaica (the ” Center “), will be speaking at the international CanEx Psychedelics Summit in Montego Bay, Jamaica taking place July 15 – 16, 2021 . ....

United States , La Haye , Zuid Holland , University Of The West Indies , Saint Andrew , Anne Donohoe , Phil Carlson , Graham Simmonds , A Johns Hopkins , Johns Hopkins University , Aion Therapeutic Inc , Faculty Of Medical Sciences , Association Of Jamaica , Ministry Of Health , Ai Pharmaceuticals Jamaica , Jamaica Fulbright Alumni Association , Johns Hopkins Center , Member Of The Medical Council Jamaica , Drug Administration , University Hospital Of The West Indies , Masters In Public Health Cum Laude , Jamaica Psychiatric Association , Strategic Communications , University Of Pecs , Jamaica The Center , National Council On Drug Abuse ,